Mirae Asset Global Investments Co. Ltd. Reduces Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

Mirae Asset Global Investments Co. Ltd. lessened its stake in Definitive Healthcare Corp. (NASDAQ:DH) by 14.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 90,238 shares of the company’s stock after selling 15,675 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Definitive Healthcare were worth $897,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in DH. Global Retirement Partners LLC boosted its holdings in shares of Definitive Healthcare by 86.0% during the third quarter. Global Retirement Partners LLC now owns 4,171 shares of the company’s stock valued at $31,000 after acquiring an additional 1,928 shares during the period. SG Americas Securities LLC acquired a new stake in Definitive Healthcare in the 3rd quarter valued at about $116,000. Valeo Financial Advisors LLC lifted its holdings in Definitive Healthcare by 50.8% in the 3rd quarter. Valeo Financial Advisors LLC now owns 73,033 shares of the company’s stock valued at $584,000 after acquiring an additional 24,604 shares during the last quarter. Raymond James & Associates lifted its holdings in Definitive Healthcare by 24.2% in the 3rd quarter. Raymond James & Associates now owns 650,327 shares of the company’s stock valued at $5,196,000 after acquiring an additional 126,613 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in Definitive Healthcare by 11.7% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,090,136 shares of the company’s stock worth $8,710,000 after buying an additional 113,963 shares during the period. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Stock Down 0.8 %

Shares of DH stock opened at $7.27 on Wednesday. The stock has a market cap of $856.33 million, a P/E ratio of -4.08, a price-to-earnings-growth ratio of 6.15 and a beta of 1.39. The stock has a fifty day moving average price of $8.28 and a 200 day moving average price of $8.31. Definitive Healthcare Corp. has a one year low of $5.53 and a one year high of $12.45. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.31 and a quick ratio of 2.31.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a negative net margin of 80.40% and a positive return on equity of 0.43%. The company had revenue of $65.93 million for the quarter, compared to the consensus estimate of $66.01 million. Analysts predict that Definitive Healthcare Corp. will post 0.11 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Stifel Nicolaus cut their price objective on Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating on the stock in a report on Wednesday, January 17th. Needham & Company LLC cut Definitive Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, January 17th. Barclays upped their target price on Definitive Healthcare from $10.00 to $11.00 and gave the stock an “equal weight” rating in a research report on Friday, March 1st. Canaccord Genuity Group cut Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Finally, Canaccord Genuity Group raised their price objective on shares of Definitive Healthcare from $9.00 to $10.00 and gave the stock a “hold” rating in a research note on Thursday, February 29th. Seven research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $11.31.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.